|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: WAVO CORP, 10-Q, 2000-08-14 |
Next: AVI BIOPHARMA INC, 10-Q/A, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
unaudited consolidated statements of operations and is qualified in its entirety
by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 4,773
<SECURITIES> 0
<RECEIVABLES> 2,679
<ALLOWANCES> 236
<INVENTORY> 1,790
<CURRENT-ASSETS> 10,447
<PP&E> 14,058
<DEPRECIATION> 7,854
<TOTAL-ASSETS> 30,302
<CURRENT-LIABILITIES> 9,611
<BONDS> 3,369
11,833
0
<COMMON> 159,369
<OTHER-SE> (151,671)
<TOTAL-LIABILITY-AND-EQUITY> 30,302
<SALES> 8,925
<TOTAL-REVENUES> 8,925
<CGS> 4,523
<TOTAL-COSTS> 4,523
<OTHER-EXPENSES> 18,942
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (96)
<INCOME-PRETAX> (12,416)
<INCOME-TAX> 0
<INCOME-CONTINUING> (12,416)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (12,416)
<EPS-BASIC> (.49)
<EPS-DILUTED> (.49)
</TABLE>
|
|